Zhejiang Medical Co., Ltd. was a large -scale joint -stock comprehensive pharmaceutical company formed in May 1997.In August 1999, with the approval of the China Securities Regulatory Commission, the company publicly issued 58 million A shares of RMB A shares to the society. In October of the same year, the companys shares were listed on the Shanghai Stock Exchange.As of the end of 2015, the registered capital was 930 million yuan and the total assets were 8.2 billion yuan.
Zhejiang Pharmaceuticals now owns five major branches (subsidiaries) such as Xinchang Pharmaceutical Factory, Vitamin Factory, Changhai Biological Branch, Zhejiang Lixi Biotechnology Co., Ltd., Zhejiang Laiyi Pharmaceutical Co., Ltd.Biopharmaceutical Research and Development Center, two R & D units, are national high -tech enterprises, national innovative enterprises, national enterprise technology centers, and national post -doctoral research stations.There are more than 6,000 employees, including more than 2,000 professional and technical personnel, accounting for more than 40 % of the total number of employees.
At present, Zhejiang Pharmaceutical has formed professional and large -scale production of fat -soluble vitamins, vitamins, pyrone antibiotics, antibiotic antibiotics and other products.Company raw material products: Vitamin E production is the largest in the world, the second largest producer in the world; natural vitamin E production is the largest in China, the third largest producer in the world; β-carotene and spotted yellowin are the largest and third largest supply in the world in the country.Business; Vancin hydrochloride and Lenin have accounted for more than 40%of global output; company preparation products: lactic acid Levofloxacin injection (product name "Lai Lixin") accounts for more than 20%of the countrys sales.Trusted) accounts for more than 30%of the national sales, and Lenin (Galin) is used as the largest domestic supplier in China.
Through the development strategy of "innovation and entrepreneurship, competition development, scientific and technological enterprises, and strong enterprises" through the conscientious implementation of the main line of product development, highlighting structural adjustments, integrating various resources, strengthening original technological innovation and advantageous productsTechnological innovation, do a good job of DMF file registration and FDA certification of advantageous varieties, vigorously promote the clean production and circular economy, use globalization as a foothold, build a complete market network, establish a good brand image, create advanced corporate culture, vigorously vigorously vigorouslyIt has enhanced the core competitiveness of the enterprise. At present, Zhejiang Pharmaceutical has developed into a medical company with advanced technology, huge scale, strong strength, and influential to the global market.